Management of Vascular Complications in Pediatric Supracondylar Humerus Fractures

March 19, 2026 updated by: Mina Mamdouh Fakher, Assiut University
  • To determine the incidence and types of vascular injuries associated with pediatric supracondylar humerus fractures.
  • Identify outcomes of different management strategies
  • Identify risk factors for vascular injury

Study Overview

Status

Not yet recruiting

Intervention / Treatment

Detailed Description

Supracondylar humerus fractures are the most common elbow fractures in children. Because the brachial artery lies anterior to the distal humerus, displaced fractures can cause:

Arterial spasm, Intimal injury, Thrombosis, Entrapment or transection) Vascular injury risk increases significantly with higher Gartland classifications of supracondylar humerus fractures, peaking in Type III and Type IV injuries.

Vascular compromise can lead to ischemia, compartment syndrome, and long-term functional deficits if not promptly identified and treated.

The decision-making around "pink pulseless hand" remains controversial Some centers advocate observation after reduction, while others recommend early exploration.

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Hesham Elsayed Aboloyon

Study Locations

      • Asyut, Egypt
        • Assiut University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • ● Children Diagnosed with supracondylar humerus fracture (Gartland I-IV) aged under 15 years.

    • Presented within 1st 48 hrs of injury.

Exclusion Criteria:

  • ● Old trauma >48 hours

    • Previous vascular intervention in the same limb
    • Another fracture in the same limb

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Non-Randomized
  • Interventional Model: Factorial Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Patients with intact pulse will be followed up for 48 hours after fixation
Other: Pink pulseless hand

): Patients with no pulse, but with good biphasic distal doppler signals, well perfused hand capillary refill time less than 3 seconds, and normal oxygen saturation.

Patients in this group will be managed by watchful observation for 48 hours after fixation. Vascular exploration will only be indicated if hand ischemia, loss of distal doppler signals, or deterioration of digital oxygen saturation occur

Patients with no pulse or distal doppler signals, and delayed capillary refill time will undergo immediate vascular exploration and injuries will be documented and managed accordingly.
Active Comparator: Pale pulseless hand
Patients with no pulse or distal doppler signals, and delayed capillary refill time will undergo immediate vascular exploration and injuries will be documented and managed accordingly.
Patients with no pulse or distal doppler signals, and delayed capillary refill time will undergo immediate vascular exploration and injuries will be documented and managed accordingly.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
incidence of vascular complications in patients with supracondylar humerus fractures
Time Frame: baseline
baseline

Secondary Outcome Measures

Outcome Measure
Time Frame
Predictors of vascular complications in pediatric supracondylar humerus fractures.
Time Frame: baseline
baseline

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

  • Dabis J, Daly K, Gelfer Y (2016): Supracondylar fractures of the humerus in children: a review of management and controversies. Orthopedic & Muscular System, 5(01): 1-4.
  • Benedetti Valentini M, Farsetti P, Martinelli O et al. (2013): The value of ultrasonic diagnosis in the management of vascular complications of supracondylar fractures of the humerus in children. The Bone & Joint Journal, 95(5): 694-698.
  • Schoenecker P, Delgado E, Rotman M et al. (1996): Pulseless arm in association with totally displaced supracondylar fracture. Journal of Orthopaedic Trauma, 10(6): 410-415
  • Farnsworth C, Silva P, Mubarak S (1998): Etiology of supracondylar humerus fractures. Journal of Pediatric Orthopaedics, 18(1): 38-42.
  • . Barr L (2014): Pediatric supracondylar humeral fractures: Epidemiology, mechanisms, and incidence during school holidays. Journal of Children's Orthopedics, 8:167-170
  • Cheng J, Lam T, Maffulli N (2001): Epidemiological features of supracondylar fractures of the humerus in Chinese children. Journal of Pediatric Orthopedics, 10(1): 63-67.
  • Leiblein, M., Weber, C., Marzi, I., Barker, J.H. and Nau, C., 2017. Neurovascular complications after supracondylar humerus fractures in children. Trauma Case Reports, 8, pp.16-19. https://doi.org/10.1016/j.tcr.2017.02.001.
  • . Hosam Roshdy M, Khaled El Alfy M, Hesham Sharaf M et al. (2016): Vascular Complications of Supracondylar Humeral Fractures in Pediatrics. Egyptian Journal of Vascular and Endovascular Surgery, 12: 1-5
  • Usman R, Jamil M, Hashmi J (2017): Management of arterial injury in children with supracondylar fracture of the humerus and a pulseless hand. Annals of Vascular Diseases, 10(4): 402-406.
  • Shaw B, Kasser J, Emans J et al. (1990): Management of vascular injuries in displaced supracondylar humerus fractures without arteriography. Journal of Orthopaedic Trauma, 4(1): 25-29
  • . Garg S, Weller A, Larson A et al. (2014): Clinical characteristics of severe supracondylar humerus fractures in children. Journal of Pediatric Orthopaedics, 34(1): 34- 39.
  • Lebowitz C, Matzon J (2018): Arterial injury in the upper extremity: evaluation, strategies, and anticoagulation management. Hand Clinics, 34(1): 85-95.
  • Mohammadzadeh M, Mohammadzadeh M, Mohammadzadeh A et al. (2012): Arterial damage accompanying supracondylar fractures of the humerus. Trauma Monthly, 16(4): 160-165
  • Wu J, Perron A, Miller M et al. (2002): Orthopedic pitfalls in the ED: pediatric supracondylar humerus fractures. The American Journal of Emergency Medicine, 20(6): 544-550.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 1, 2026

Primary Completion (Estimated)

April 1, 2027

Study Completion (Estimated)

May 1, 2027

Study Registration Dates

First Submitted

March 7, 2026

First Submitted That Met QC Criteria

March 19, 2026

First Posted (Actual)

March 23, 2026

Study Record Updates

Last Update Posted (Actual)

March 23, 2026

Last Update Submitted That Met QC Criteria

March 19, 2026

Last Verified

March 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • supracodylar humerus fractures

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Supracondylar Humerus Fracture

Clinical Trials on vascular exploration

Subscribe